Pharmocann develops and produces Israeli medical cannabis on a farm located in the valley of Jezreel, the Galilee. The farm has hothouses for cannabis growth and propagation; a hothouse for the research and development of various cannabis strains; and other facilities required for the cultivation, harvesting, and production of medical cannabis. The company is also a developer of medical marijuana cultivation centers and dispensaries. Pharmocann has established a strategic partnership with medical cannabis labs to produce standardized, validated, and GMP-manufactured medical cannabis products. Its line of products includes oil, ointments, tablets, inhalers, rectal and vaginal suppositories, and pre-rolled cigarettes of various types of THC/CBD strains. Pharmocann’s latest developments include hydrogel products for the treatment of certain painful diseases, acute dermatological diseases, and inflammatory bowl diseases. Pharmocann serves more than 3,000 patients a month and yields about two tons of medical cannabis yearly.